We additionally found that among those associations lack of statistical significance, five polymorphisms (two of ERCC4 and three of ERCC5) had no evidence of relationship with four cancers risk in meta-analyses with at least 3,000 cases and 3,000 controls (Table 2). The gene discussed is ERCC5; the disease is cancer.